These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7059424)

  • 1. Bioavailability of sublingual ergotamine.
    Tfelt-Hansen P; Paalzow L; Ibraheem JJ
    Br J Clin Pharmacol; 1982 Feb; 13(2):239-40. PubMed ID: 7059424
    [No Abstract]   [Full Text] [Related]  

  • 2. Plethysmographic comparison of sublingual and intramuscular ergotamine.
    Winsor T
    Clin Pharmacol Ther; 1981 Jan; 29(1):94-9. PubMed ID: 7460479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.
    Sanders SW; Haering N; Mosberg H; Jaeger H
    Eur J Clin Pharmacol; 1986; 30(3):331-4. PubMed ID: 3732370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):355-60. PubMed ID: 520404
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial infarction following administration of sublingual ergotamine.
    Klein LS; Simpson RJ; Stern R; Hayward JC; Foster JR
    Chest; 1982 Sep; 82(3):375-6. PubMed ID: 7105868
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():7-9. PubMed ID: 6935862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine absorption and toxicity.
    Orton DA; Richardson RJ
    Postgrad Med J; 1982 Jan; 58(675):6-11. PubMed ID: 7088766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buccal absorption of ergotamine.
    Sutherland JM; Hooper WD; Eadie MJ; Tyrer JH
    J Neurol Neurosurg Psychiatry; 1974 Oct; 37(10):1116-20. PubMed ID: 4443807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergotamine pharmacokinetics in man: an editorial.
    Eadie MJ
    Cephalalgia; 1983 Sep; 3(3):135-8. PubMed ID: 6627380
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic availability of ergotamine tartrate in continuous medication.
    Myllylä VV; Ala-Hurula V; Arvela P; Kärki N; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():20-2. PubMed ID: 6935854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low biological availability of ergotamine tartrate after oral dosing in cluster headache.
    Ekbom K; Paalzow L; Waldenlind E
    Cephalalgia; 1981 Dec; 1(4):203-7. PubMed ID: 6812961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of ergotamine in migraine and cluster headache.
    Perrin VL
    Clin Pharmacokinet; 1985; 10(4):334-52. PubMed ID: 3899452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ergotamine concentrations].
    Naess K
    Tidsskr Nor Laegeforen; 1979 Nov; 99(32):1669. PubMed ID: 531851
    [No Abstract]   [Full Text] [Related]  

  • 14. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Br J Clin Pharmacol; 1983 Dec; 16(6):695-9. PubMed ID: 6419759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.
    Dixon RM; Meire HB; Evans DH; Watt H; On N; Posner J; Rolan PE
    Cephalalgia; 1997 Oct; 17(6):639-46. PubMed ID: 9350383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
    Láinez MJ; Galván J; Heras J; Vila C
    Eur J Neurol; 2007 Mar; 14(3):269-75. PubMed ID: 17355546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol and ergotamine tartrate.
    Diamond S
    N Engl J Med; 1973 Jul; 289(3):159. PubMed ID: 4711350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 20. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
    Straehl P; Galeazzi RL
    Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.